Invention Grant
- Patent Title: Compositions and methods for treatment of retinal degenerative diseases
-
Application No.: US15532116Application Date: 2015-12-03
-
Publication No.: US10682328B2Publication Date: 2020-06-16
- Inventor: Zeev Dvashi , Ayala Pollack
- Applicant: MOR RESEARCH APPLICATIONS LTD.
- Applicant Address: IL Tel Aviv
- Assignee: MOR RESEARCH APPLICATIONS LTD.
- Current Assignee: MOR RESEARCH APPLICATIONS LTD.
- Current Assignee Address: IL Tel Aviv
- Agency: JMB Davis Ben-David
- International Application: PCT/IL2015/051174 WO 20151203
- International Announcement: WO2016/088125 WO 20160609
- Main IPC: A61K31/223
- IPC: A61K31/223 ; A61K31/40 ; A61K9/00 ; A61K45/06 ; A61K38/05 ; A61P25/28 ; A61P27/02
Abstract:
This disclosure relates to compositions for use in treatment of Alzheimer's Disease, and/or a ocular and retinal degenerative disease, such as age related macular degeneration. The described compositions include effective amounts of LLMe, the hydrobromide form thereof, or functional derivatives thereof. Methods of treatment of a retinal degenerative disease of Alzheimer's Disease using the described compositions are also provided.
Public/Granted literature
- US20170266146A1 COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES Public/Granted day:2017-09-21
Information query
